Select Medical (SEM) Expected to Announce Quarterly Earnings on Thursday

Select Medical (NYSE:SEM) is projected to release its Q4 2025 results after the market closes on Thursday, February 19th. Analysts expect Select Medical to post earnings of $0.23 per share and revenue of $1.3641 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q4 2025 earning overview page for the latest details on the call scheduled for Friday, February 20, 2026 at 9:00 AM ET.

Select Medical Price Performance

SEM stock opened at $16.39 on Wednesday. The stock has a market capitalization of $2.03 billion, a price-to-earnings ratio of 19.05, a PEG ratio of 0.57 and a beta of 1.25. The firm’s 50-day moving average price is $15.28 and its two-hundred day moving average price is $14.01. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.87. Select Medical has a 12-month low of $11.65 and a 12-month high of $19.54.

Wall Street Analyst Weigh In

SEM has been the topic of a number of research analyst reports. Weiss Ratings restated a “sell (d+)” rating on shares of Select Medical in a report on Wednesday, January 21st. Wall Street Zen upgraded Select Medical from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Benchmark reaffirmed a “buy” rating on shares of Select Medical in a research note on Monday, October 27th. Finally, Mizuho set a $17.00 price target on shares of Select Medical in a report on Monday, November 3rd. Four investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $17.80.

Institutional Investors Weigh In On Select Medical

Several institutional investors and hedge funds have recently made changes to their positions in SEM. 8 Knots Management LLC bought a new position in Select Medical in the 2nd quarter valued at approximately $26,568,000. Millennium Management LLC raised its stake in shares of Select Medical by 407.9% in the third quarter. Millennium Management LLC now owns 1,590,339 shares of the health services provider’s stock worth $20,420,000 after purchasing an additional 1,277,233 shares during the last quarter. Adage Capital Partners GP L.L.C. bought a new position in shares of Select Medical during the fourth quarter valued at $17,603,000. Price T Rowe Associates Inc. MD increased its holdings in Select Medical by 4.3% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,606,269 shares of the health services provider’s stock worth $246,604,000 after buying an additional 684,695 shares in the last quarter. Finally, Qube Research & Technologies Ltd purchased a new position in Select Medical in the 3rd quarter worth about $7,401,000. Institutional investors own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.